CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Operating expenses:
Research and development	$ 29,464	$ 20,198	$ 83,498	$ 65,148
General and administrative	6,313	7,088	26,283	25,888
Total operating expenses	35,777	27,286	109,781	91,036
Loss from operations	(35,777)	(27,286)	(109,781)	(91,036)
Other income, net:
Interest income	2,245	3,852	7,621	12,198
Other income, net	206	1,719	634	2,163
Total other income, net	2,451	5,571	8,255	14,361
Net loss	(33,326)	(21,715)	(101,526)	(76,675)
Other comprehensive loss:
Net unrealized (loss) gain on investments	(571)	174	(1,403)	(138)
Comprehensive loss	$ (33,897)	$ (21,541)	$ (102,929)	$ (76,813)
Net loss per share, basic	$ (0.45)	$ (0.29)	$ (1.36)	$ (1.04)
Net loss per share, diluted	$ (0.45)	$ (0.29)	$ (1.36)	$ (1.04)
Weighted average shares used to compute net loss per share, basic	74,637,689	74,024,543	74,464,897	73,973,278
Weighted average shares used to compute net loss per share, diluted	74,637,689	74,024,543	74,464,897	73,973,278